Skip to main content

Table 3 Baseline characteristics of the subjects according to metabolic obesity phenotypes in 2005 (n = 202)

From: Effect of metabolically healthy obesity on the development of arterial stiffness: a prospective cohort study

Characteristics MHNO MUNO MHO MUO P
N 105 51 23 23
Gender (M/F) 58/47 26/25 13/10 17/5 0.207
Age (years) 28.0 (27.0–32.0) 29.0 (26.0–32.0) 31.0 (29.0–33.0) 29.0 (27.0–31.0) 0.041
Current smoking (%) 33 (31.4) 17 (33.3) 12 (52.2) 10 (43.5) 0.232
Alcohol consumption (%) 33 (31.4) 19 (37.3) 10 (43.5) 12 (47.8) 0.402
Hypertension (n, %) 10 (9.5) 13 (25.5) 3 (13.0) 10 (43.5) 0.001
BMI (kg/m2) 21.4 (19.9–23.1) 22.1 (20.0–23.3) 25.6 (25.3–26.5) 27.5 (25.8–29.4) < 0.001
Heart rate (beats/min) 72.0 (67.5–76.0) 74.0 (68.0–80.0) 78.0 (70.0–84.0) 70.0 (66.0–84.0) 0.147
SBP (mmHg) 117.1 ± 13.7 125.4 ± 21.1 117.4 ± 14.7 133.5 ± 15.3 < 0.001
DBP (mmHg) 74.2 ± 9.9 81.3 ± 14.0 77.1 ± 10.8 87.9 ± 8.9 < 0.001
Fasting glucose (mmol/L) 4.59 ± 0.56 4.85 ± 0.78 4.67 ± 0.46 5.39 ± 0.71 < 0.001
Total cholesterol (mmol/L) 4.41 ± 0.70 4.05 ± 0.80 4.61 ± 0.67 4.38 ± 0.61 0.014
Triglycerides (mmol/L) 1.10 (0.90–1.30) 1.50 (0.98–1.90) 1.30 (0.93–1.50) 1.90 (1.30–2.30) < 0.001
LDL- cholesterol (mmol/L) 2.62 ± 0.47 2.44 ± 0.45 2.70 ± 0.39 2.64 ± 0.36 0.055
HDL- cholesterol (mmol/L) 1.12 ± 0.19 1.02 ± 0.18 1.16 ± 0.16 1.09 ± 0.15 0.010
SUA (μmol/L) 1.24 ± 0.27 1.19 ± 0.23 1.14 ± 0.18 1.04 ± 0.24 0.008
Serum creatinine (μmol/L) 2.55 (2.13–2.89) 2.55 (2.01–3.05) 2.58 (2.04–2.97) 2.42 (1.91–2.78) 0.313
Urine albumin (mg/L) 8.30 (4.55–13.65) 10.70 (4.90–24.80) 12.70 (5.80–38.90) 15.70 (6.60–29.90) 0.046
uACR (mg/mmol) 1.01 (0.66–1.84) 1.25 (0.65–3.14) 1.18 (0.78–3.73) 1.31 (0.58–9.03) 0.224
eGFR (ml/min/1.73 m2) 98.78 ± 17.80 105.02 ± 16.77 105.63 ± 23.03 104.36 ± 28.72 0.205
C-reactive protein (mg/L) 0.32 (0.18–0.68) 0.36 (0.16–0.85) 0.50 (0.29–0.90) 0.90 (0.38–2.04) 0.007
  1. BMI body mass index, MHNO metabolically healthy nonobesity, MUNO metabolically unhealthy nonobesity, MHO metabolically healthy obesity, MUO metabolically unhealthy obesity, SBP systolic blood pressure, DBP diastolic blood pressure, LDL low-density lipoprotein, HDL high-density lipoprotein, SUA serum uric acid, uACR urinary albumin-to-creatinine ratio, eGFR estimated glomerular filtration rate. Non-normally distributed variables are expressed as the median (interquartile range). All other values are expressed as mean ± SD or n, %